Octenidinedihydrochlorid

DRUG2 trials

Sponsors

Schülke & Mayr GmbH

Conditions

Inhibition of Plaque Formation (by Gingivitis-Index ≤1.5)

Phase 3

Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

CompletedNCT03322124

Schülke & Mayr GmbHInhibition of Plaque Formation (by Gingivitis-Index ≤1.5)

Start: 2018-01-22End: 2018-12-14Updated: 2019-01-22

Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

CompletedNCT03378401

Schülke & Mayr GmbHInhibition of Plaque Formation (by Gingivitis-Index ≤1.5)

Start: 2018-01-11End: 2018-09-14Updated: 2018-11-06